^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Anal Carcinoma |
| Regimen: | TPF (5-fluorouracil + cisplatin + docetaxel) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Anal carcinoma: Modified docetaxel/cisplatin/fluorouracil (category 2B) was added as treatment option for metastatic disease.
